Substituted 3Ј-thiourea derivatives of -thymidine (dThd) and 5Ј-thiourea derivatives of ␣-dThd have been evaluated for their inhibitory activity against recombinant human cytosolic dThd kinase-1 (TK-1), human mitochondrial TK-2, herpes simplex virus type 1 (HSV-1) TK, and varicella-zoster virus TK. Several substituted 3Ј-thiourea derivatives of -dThd proved highly inhibitory to and selective for TK-2 (IC 50 value, 0.15-3.1 M). The 3Ј-C-branched p-methylphenyl (compound 1) and 3-CF 3 -4-Cl-phenyl (compound 7) thiourea derivatives of -dThd showed competitive inhibition of TK-2 when dThd was used as the variable substrate (K i values, 0.40 and 0.05 M, respectively), but uncompetitive inhibition in the presence of variable concentrations of ATP (K i values, 15 and 2.0 M, respectively). These kinetic properties of compounds 1 and 7 against TK-2 could be accounted for by molecular modeling showing that two hydrogen bonds can be formed between the thiourea nitrogens of compound 7 and the oxygens of the ␥-phosphate of ATP. The importance of several active-site residues was assessed by site-directed mutagenesis experiments on TK-2 and the related HSV-1 TK. The low K i /K m ratios for compounds 1 and 7 (0.38 and 0.039 against dThd, and 0.75 and 0.12 against ATP, respectively) indicate that these compounds are among the most potent inhibitors of TK-2 described so far. In addition, a striking close correlation was found between the inhibitory activities of the test compounds against TK-2 and Mycobacterium tuberculosis thymidylate kinase that is strongly indicative of close structural and/or functional similarities between both enzymes in relation to their mode of interaction with these nucleoside analog inhibitors.